País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Guaifenesin; Phenylephrine hydrochloride; Paracetamol
Haleon UK Ltd
N02BE51
Guaifenesin; Phenylephrine hydrochloride; Paracetamol
200mg ; 12.2mg ; 1gram
Powder for oral solution
Oral
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: ; GTIN: 5000347038242
BEECHAMS MAX STRENGTH ALL IN ONE HOT LEMON MENTHOL FLAVOUR POWDER FOR ORAL SOLUTION PARACETAMOL, GUAIFENESIN, PHENYLEPHRINE PATIENT INFORMATION LEAFLET 6110846 READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU TAKE THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION YOU NEED TO KNOW. This medicine is available without prescription, however, you still need to use this product carefully to get the best results from it. Keep this leaflet as you may need to read it again. Ask your pharmacist if you need more information or advice. 1. WHAT IS THIS MEDICINE AND WHAT IS IT USED FOR? THIS MEDICINE CONTAINS: • PARACETAMOL which is a pain reliever (analgesic) and helps reduce your temperature when you have a fever • GUAIFENESIN which is an expectorant to help loosen phlegm • PHENYLEPHRINE which is a decongestant to reduce swelling in the passages of the nose to help you breathe more easily. These sachets are used for the relief of the symptoms of colds and flu and the pain and congestion of sinusitis, including aches and pains, headache, blocked nose and sore throat, chills and feverishness (high temperature). They can also loosen stubborn mucus (phlegm) and provide relief from chesty coughs. 2. IS THIS MEDICINE SUITABLE FOR YOU? DO NOT TAKE THIS MEDICINE IF YOU: • are ALLERGIC to paracetamol, guaifenesin, phenylephrine or any of the other ingredients (listed in section 6) • have a serious heart condition or cardiovascular disorder(s) • have high blood pressure (hypertension) • have an overactive thyroid • have glaucoma, including closed angle glaucoma • have difficulty passing urine • are taking antidepressant drugs called monoamine oxidase inhibitors (MAOI’s), or have taken them within the last 14 days - these are medicines such as phenelzine, isocarboxazid and tranylcypromine • are taking beta-blocking drugs • are currently taking other decongestant drugs (e.g. ephedrine, pseudoephedrine and xylometazoline) or stimulants (e.g. dexamfetamine) • are taking a cough medicine called a cough suppre Leia o documento completo
OBJECT 1 BEECHAMS MAX STRENGTH ALL IN ONE HOT LEMON MENTHOL FLAVOUR POWDER FOR ORAL SOLUTION Summary of Product Characteristics Updated 13-Mar-2015 | GlaxoSmithKline Consumer Healthcare 1. Name of the medicinal product Beechams Max Strength All in One Hot Lemon Menthol Flavour powder for oral solution 2. Qualitative and quantitative composition ACTIVE INGREDIENT Paracetamol Guaifenesin Phenylephrine hydrochloride MG/SACHET 1000 200 12.2 This product also contains the excipients sucrose, aspartame and sodium (as sodium citrate) - see section 4.4. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for oral solution. Sachets containing the drug product, an off-white powder. 4. Clinical particulars 4.1 Therapeutic indications For the relief of symptoms associated with colds and flu and the pain and congestion of sinusitis, including aches and pains, headache, blocked nose and sore throat, chills, lowering of temperature, and to loosen stubborn mucous and provide relief from chesty coughs. 4.2 Posology and method of administration For oral use after dissolving the contents of the sachet in a standard mug of hot, but not boiling water (250 ml). Allow to cool to a drinkable temperature. Adults, the elderly and children aged 12 years and over: One sachet every four hours as required. Do not take more than 4 sachets (4 doses) in any 24 hour period. Do not give to children under 12 years old. 4.3 Contraindications Hypersensitivity to any of the ingredients. Severe heart disease and cardiovascular disorders. Hypertension. Hyperthyroidism. Contraindicated in patients currently receiving or within two weeks of stopping therapy with monoamine oxidase inhibitors. Use in patients with glaucoma or urinary retention. Use in patients who are currently receiving other sympathomimetic drugs. 4.4 Special warnings and precautions for use The physician or pharmacist should check that sympathomimetic-containing preparations are not simultaneously administered by several routes i.e. orally and topically (nasal, Leia o documento completo